Kinexcs is an AI-driven digital health platform and wearables company with a mission to enable and empower people for mobility and a better quality of life. It is focused on reducing the burden of musculoskeletal conditions, which affects about 25% of the world's population. Their 1st product, KIMIA Recover, a continuous monitoring device for the knee joint, has obtained FDA Approval, CE marking and HSA approval, and booked revenues from large implant companies and hospitals. It has recently won the Johnson and Johnson Quickfire Challenge Award, Innomatch grant by the Temasek Foundation (one of the 6 among 256 companies across 32 countries), and is currently deployed in some of the largest public hospitals in Singapore. KIMIA Recover is a comprehensive recovery management solution providing reduction in number of hospital visits and complications. The product was also the National Winner and International Top 20 of the prestigious James Dyson Award 2020, and has gained traction with major public hospitals and orthopaedic clinics.
Their digital therapy platform, consisting of KIMIA Assess and KIMIA PT products, uses artificial intelligence technology for digital MSK assessment and therapy. This platform is capable of providing pre-consultation assessments and real-time exercise guidance and feedback to musculoskeletal patients, and is being adopted by some of the largest private healthcare providers in the region, along with large corporate players.